In a Press briefing by Adar Poonawalla, CEO, Serum Insititute of India has said “Vaccine will be distributed initially in India, then we will look at the COVAX countries which are mainly in Africa. The UK & European markets are being taken care of by AstraZeneca & Oxford. Our priority is India & COVAX countries.”
On emergency license for manufacturing of COVID-19 vaccine COVISHIELD, he said “We are in the process of applying for emergency use authorization of Covishield in the next two weeks.”
In a major healthcare development, Noida’s Sector 39 district hospital has started providing anti-rabies serum…
The Indian Premier League (IPL), since its inception in 2008, has grown into one of…
In a groundbreaking study, Dr. Swapan Kumar Ghosh, a distinguished researcher from Bengal, has identified…
A recent report has raised concerns as over 54% of households in Delhi-NCR have been…
Anxiety is a natural response to stress, but for many people, it can become overwhelming…
Painkillers, particularly nonsteroidal anti-inflammatory drugs (NSAIDs), are commonly used to alleviate pain and inflammation. However,…